OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
LPCN
Lipocine Inc.
Common Stock
3.20
-0.065
-1.99%
Delayed (15 Min) Trade Data: 12:00am 07/14/2025
Business Description
Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders.
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0001535955
Fiscal Year End
12/31
Company Officers & Contacts
Mahesh V. Patel
President, CEO
Morgan Brown
EVP, CFO
Srinivasan Venkatesh
CTO
Board of Directors
Not available
Other Company Insiders
Not available
Service Providers
Accounting/Auditing Firm
KPMG55 Second Street, Suite 1400
San Francisco, CA 94105
Profile Data
SIC - Industry Classification
2834 - Pharmaceutical preparations
Incorporation Information
DE, US, 2011
Employees
Not Available
Shell
No
Products and Services
Not available
Company Facilities
Not available
Company Notes
Formerly=Marathon Bar Corporation until 7-2013
Loading...
Symbol
OTCM
Last
57.3755
Change
-0.0345 (-0.06%)
Bid
56.30
Ask
57.50
Volume
2595
Time
00:00
